Trials / Active Not Recruiting
Active Not RecruitingNCT03349528
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Sheppard Pratt Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Probiotic Supplement | Probiotic supplement 1 tablet by mouth daily |
| BIOLOGICAL | Inert Compound | Probiotic identical placebo 1 tablet by mouth daily |
Timeline
- Start date
- 2018-12-11
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2017-11-21
- Last updated
- 2026-04-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03349528. Inclusion in this directory is not an endorsement.